Wolfe Med Tools: Doctor Dili on Proposed TAVR NCD – Feedback on the Updates

Research evidence excerpt

Wolfe Med Tools: Doctor Dili on Proposed TAVR NCD – Feedback on the Updates

Medical Supplies & Devices

Medical Supplies & Devices - Market Weight

Wolfe Med Tools: Doctor Dili on Proposed TAVR NCD – June 30, 2026

Feedback on the Updates

The Wolfe Byte

Proposed TAVR NCD turned over two Mondays ago. On surface updates are supportive of TAM expansion, efficiency

gains at existing centers, & opening new centers. We got fresh feedback from two interventional cardiologists.

ICYMI – Wolfe dili on the TAVR NCD so far, in chronological order:

EW: Spotlight on Solicited Advice – Sift Through TAVR National Coverage Analysis Public Comments (1/15/26)

Dr. Conway (March 16) - REPLAY (31:28)

Dr. Narayan (March 20) - REPLAY (54:36)

Dr. Goldsweig (May 11) - REPLAY (20:11; 26:14)

Dr. Shah (May 11) - REPLAY (16:32)

EW: TAVR 4 More - Proposed NCD Adjusted Positively on All Fronts of the Debate (6/15/26)

On to the freshest of feedback…we heard from two interventional cardiologists.

Dr. Andrew Goldsweig – interventional cardiologist and Director of Heart and Vascular at Bay State Cardiology in

Springfield, MA. His institution does about 425 TAVRs per year.

●Existing TAVR center efficiencies: Dr. Goldsweig believes dropping dual operator requirement and two-clinic-

visit requirement will increase TAVR volumes by +5%-10%. Effective immediately upon NCD implementation, no

two-operator requirement may allow for scheduling a few more TAVRs in slots when previously a surgeon was

unavailable. However, scheduling the surgeon not a major rate-limiter in his experience. Only one clinic visit will

increase clinic bandwidth substantially, but cardiac surgeons may push back.

●Dropping center volume requirements = ‘new store growth’: Sees a delayed increase in TAVR volumes to come